The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
January 28, 2019
Abstract : Hainan Poly Pharm. Co., Ltd. (300630.SZ)announced that it received an approval from Food and Drug Administration (FDA) for selling eptifibatide injection in the United States.
BEIJING, Jan. 28 (Xinhua) -- Hainan Poly Pharm. Co., Ltd. (300630.SZ) announced that it received an approval from Food and Drug Administration (FDA) for selling eptifibatide injection in the United States.
The approval will cast a positive influence on the company’s expansion plan in the American market. (Edited by Ma Xin, maxin11@xinhua.org)
Most Read
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
A single purchase
